Oncoproteomic profiling with antibody microarrays

The incidence of cancer and its associated mortality are increasing globally, indicating an urgent need to develop even more effective and sensitive sets of biomarkers that could help in early diagnosis and consequent intervention. Given that many cellular processes are carried out by proteins, cancer research has recently shifted toward an exploration of the full proteome for such discovery. Among the advanced methodologies that are being developed for analyzing the proteome, antibody microarrays have become a prominent tool for gathering the information required for a better understanding of disease biology, early detection, discrimination of tumors and monitoring of disease progression. Here, we review the technical aspects and challenges in the development and use of antibody microarray assays and examine recently reported applications in oncoproteomics.

[1]  J. Brunet,et al.  Overexpression of fatty acid synthase gene activates HER1/HER2 tyrosine kinase receptors in human breast epithelial cells , 2008, Cell proliferation.

[2]  Daohai Zhang,et al.  Tyrosine phosphorylation of PP2A is regulated by HER-2 signalling and correlates with breast cancer progression. , 2009, International journal of oncology.

[3]  J. Hoheisel,et al.  Antibody microarrays: promises and problems. , 2002, BioTechniques.

[4]  H. Lehrach,et al.  Subnanoliter enzymatic assays on microarrays , 2005, Proteomics.

[5]  R. Ekins,et al.  Multi-analyte immunoassay. , 1989, Journal of pharmaceutical and biomedical analysis.

[6]  A. Ivanov,et al.  Comparative proteomic and transcriptomic profiling of the fission yeast Schizosaccharomyces pombe , 2007, Molecular systems biology.

[7]  M. Uhlén,et al.  Generation and validation of affinity reagents on a proteome‐wide level , 2009, Journal of molecular recognition : JMR.

[8]  K. Sandelin,et al.  Proteomic Characterization of the Interstitial Fluid Perfusing the Breast Tumor Microenvironment , 2004, Molecular & Cellular Proteomics.

[9]  David E. Misek,et al.  Distinctive serum protein profiles involving abundant proteins in lung cancer patients based upon antibody microarray analysis , 2005, BMC Cancer.

[10]  Mårten Fernö,et al.  Serum proteome profiling of metastatic breast cancer using recombinant antibody microarrays. , 2008, European journal of cancer.

[11]  Dean Brenner,et al.  Multiplexed analysis of glycan variation on native proteins captured by antibody microarrays , 2007, Nature Methods.

[12]  B. Haab.  Methods and applications of antibody microarrays in cancer research , 2003, Proteomics.

[13]  Evan R Hirst,et al.  Bond-rupture immunosensors--a review. , 2008, Biosensors & bioelectronics.

[14]  Gavin MacBeath,et al.  Protein microarrays and proteomics , 2002, Nature Genetics.

[15]  F W Chu,et al.  Multianalyte microspot immunoassay--microanalytical "compact disk" of the future. , 1991, Clinical chemistry.

[16]  I. Kohane,et al.  Mass spectrometry-based study of the plasma proteome in a mouse intestinal tumor model. , 2006, Journal of proteome research.

[17]  David E. Gloriam,et al.  ProteomeBinders: planning a European resource of affinity reagents for analysis of the human proteome , 2007, Nature Methods.

[18]  J. Hoheisel,et al.  Solid supports for microarray immunoassays , 2003, Journal of molecular recognition : JMR.

[19]  T. Barrette,et al.  Profiling of cancer cells using protein microarrays: discovery of novel radiation-regulated proteins. , 2001, Cancer research.

[20]  Johan Ingvarsson,et al.  Design of recombinant antibody microarrays for cell surface membrane proteomics. , 2008, Journal of proteome research.

[21]  J. Delrow,et al.  Use of high density antibody arrays to validate and discover cancer serum biomarkers , 2007, Molecular oncology.

[22]  Soo-Ik Chang,et al.  Profiling of differential protein expression in angiogenin‐induced HUVECs using antibody‐arrayed ProteoChip , 2006, Proteomics.

[23]  Tim W. Nattkemper,et al.  Peak intensity prediction in MALDI-TOF mass spectrometry: A machine learning study to support quantitative proteomics , 2008, BMC Bioinformatics.

[24]  E. B. Butler,et al.  Antibody microarray profiling of human prostate cancer sera: Antibody screening and identification of potential biomarkers , 2003, Proteomics.

[25]  J. Hoheisel.  Microarray technology: beyond transcript profiling and genotype analysis , 2006, Nature Reviews Microbiology.

[26]  T. Pohl,et al.  Two‐dimensional gel electrophoresis as tool for proteomics studies in combination with protein identification by mass spectrometry , 2006, Proteomics.

[27]  W. Ansorge.  Next-generation DNA sequencing techniques. , 2009, New biotechnology.

[28]  Mike Scott,et al.  Analysis of human leukaemias and lymphomas using extensive immunophenotypes from an antibody microarray , 2006, British journal of haematology.

[29]  H. Lehrach,et al.  Toward optimized antibody microarrays: a comparison of current microarray support materials. , 2002, Analytical biochemistry.

[30]  Ashok Mulchandani,et al.  Single conducting polymer nanowire chemiresistive label-free immunosensor for cancer biomarker. , 2009, Analytical chemistry.

[31]  Carsten Peterson,et al.  Detection of pancreatic cancer using antibody microarray‐based serum protein profiling , 2008, Proteomics.

[32]  Gesine Hansen,et al.  Comparative application of antibody and gene array for expression profiling in human squamous cell lung carcinoma. , 2005, Lung cancer.

[33]  R. Christopherson,et al.  Multiplex detection of surface molecules on colorectal cancers , 2006, Proteomics.

[34]  William C Hahn,et al.  Rules for making human tumor cells. , 2002, The New England journal of medicine.

[35]  Michelle A. Anderson,et al.  Pancreatic cancer serum detection using a lectin/glyco-antibody array method. , 2009, Journal of proteome research.

[36]  W. Isaacs,et al.  Cytokine profiling of prostatic fluid from cancerous prostate glands identifies cytokines associated with extent of tumor and inflammation , 2008, The Prostate.

[37]  F. Pontén,et al.  Towards a human proteome atlas: High‐throughput generation of mono‐specific antibodies for tissue profiling , 2005, Proteomics.

[38]  Lars Montelius,et al.  Design of atto‐vial based recombinant antibody arrays combined with a planar wave‐guide detection system , 2007, Proteomics.

[39]  Shiyong Li,et al.  Identification of interleukin‐8 as estrogen receptor‐regulated factor involved in breast cancer invasion and angiogenesis by protein arrays , 2004, International journal of cancer.

[40]  G. Zhou,et al.  Protein Expression Profiling of Breast Cancer Cells by Dissociable Antibody Microarray (DAMA) Staining*S , 2008, Molecular & Cellular Proteomics.

[41]  H. Yoshiji,et al.  Identification of c-Yes expression in the nuclei of hepatocellular carcinoma cells: involvement in the early stages of hepatocarcinogenesis. , 2007, International journal of oncology.

[42]  J. Menéndez,et al.  Protein array technology to detect HER2 (erbB-2)-induced 'cytokine signature' in breast cancer. , 2007, European journal of cancer.

[43]  E. Kubista,et al.  Use of High-Throughput Protein Array for Profiling of Differentially Expressed Proteins in Normal and Malignant Breast Tissue , 2004, Breast Cancer Research and Treatment.

[44]  R. Aebersold,et al.  Mass spectrometry-based proteomics , 2003, Nature.

[45]  P. Nelson,et al.  From genomics to proteomics: techniques and applications in cancer research. , 2001, Trends in cell biology.

[46]  L. Lechuga,et al.  Biosensors based on cantilevers. , 2009, Methods in molecular biology.

[47]  B. Garvik,et al.  Use of cancer-specific yeast-secreted in vivo biotinylated recombinant antibodies for serum biomarker discovery , 2008, Journal of Translational Medicine.

[48]  Johan Ingvarsson,et al.  Design of recombinant antibody microarrays for complex proteome analysis: Choice of sample labeling‐tag and solid support , 2007, Proteomics.

[49]  Ziding Feng,et al.  Optimized Normalization for Antibody Microarrays and Application to Serum-Protein Profiling*S , 2005, Molecular & Cellular Proteomics.

[50]  A. Partin,et al.  Antibody array profiling reveals serum TSP‐1 as a marker to distinguish benign from malignant prostatic disease , 2007, The Prostate.

[51]  A. Heck,et al.  Surface plasmon resonance mass spectrometry in proteomics , 2008, Expert review of proteomics.

[52]  P. Morávek,et al.  Determination of angiogenic factors in serum by protein array in patients with renal cell carcinoma. , 2008, Folia biologica.

[53]  Albert Duschl,et al.  specimens: systematic evaluation of labeling strategies , 2006 .

[54]  C. Borrebaeck,et al.  Antibody microarrays: current status and key technological advances. , 2006, Omics : a journal of integrative biology.

[55]  R. Aebersold,et al.  Mass spectrometry in proteomics. , 2001, Chemical reviews.

[56]  I. Gromova,et al.  Identification of Extracellular and Intracellular Signaling Components of the Mammary Adipose Tissue and Its Interstitial Fluid in High Risk Breast Cancer Patients , 2005, Molecular & Cellular Proteomics.

[57]  A. Butte,et al.  AILUN: reannotating gene expression data automatically , 2007, Nature Methods.

[58]  J. Saldanha,et al.  MP470, a novel receptor tyrosine kinase inhibitor, in combination with Erlotinib inhibits the HER family/PI3K/Akt pathway and tumor growth in prostate cancer , 2009, BMC Cancer.

[59]  貴子 野々村.  Identification of c-Yes expression in the nuclei of hepatocellular carcinoma cells : involvement in the early stages of hepatocarcinogenesis , 2007 .

[60]  A. Yoshimura,et al.  Gemcitabine resistance in a highly metastatic subpopulation of a pulmonary adenocarcinoma cell line resistant to gefitinib. , 2007, International journal of oncology.

[61]  Jörg Hoheisel,et al.  Subcellular protein extraction from human pancreatic cancer tissues. , 2009, BioTechniques.

[62]  Ziding Feng,et al.  Antibody microarray profiling reveals individual and combined serum proteins associated with pancreatic cancer. , 2005, Cancer research.

[63]  Igor Goychuk,et al.  Optimal Design of Microarray Immunoassays to Compensate for Kinetic Limitations , 2006, Molecular & Cellular Proteomics.

[64]  D. Jukic,et al.  SAGE and antibody array analysis of melanoma-infiltrated lymph nodes: identification of Ubc9 as an important molecule in advanced-stage melanomas , 2007, Oncogene.

[65]  Y. Qu,et al.  IPO-38 is identified as a novel serum biomarker of gastric cancer based on clinical proteomics technology. , 2008, Journal of proteome research.

[66]  Marta Sanchez-Carbayo,et al.  Antibody arrays: technical considerations and clinical applications in cancer. , 2006, Clinical chemistry.

[67]  C. Borrebaeck,et al.  High-throughput proteomics using antibody microarrays , 2004, Expert review of proteomics.

[68]  T. Veenstra,et al.  Characterization of the Low Molecular Weight Human Serum Proteome*S , 2003, Molecular & Cellular Proteomics.

[69]  Whole serum BSA antibody screening using a label-free biophotonic nanoparticle array. , 2009, Analytical biochemistry.

[70]  N. Socci,et al.  Profiling bladder cancer using targeted antibody arrays. , 2006, The American journal of pathology.

[71]  Ildikó Horváth,et al.  Differential Cytokine Pattern in the Exhaled Breath of Patients with Lung Cancer , 2008, Pathology & Oncology Research.

[72]  V. Santoni,et al.  Detergents and chaotropes for protein solubilization before two-dimensional electrophoresis. , 2009, Methods in molecular biology.

[73]  J. Casal,et al.  A Proteomics Analysis of Cell Signaling Alterations in Colorectal Cancer*S , 2007, Molecular & Cellular Proteomics.

[74]  Mathias Uhlén,et al.  Affinity as a tool in life science. , 2008, BioTechniques.

[75]  M. Kasper,et al.  RNA expression profiling at the single molecule level. , 2006, Genome research.

[76]  Candida N. Perera,et al.  Identification of Proteins Secreted from Leptin Stimulated MCF-7 Breast Cancer Cells: A Dual Proteomic Approach , 2008, Experimental biology and medicine.

[77]  P. Drew,et al.  The analysis of doxorubicin resistance in human breast cancer cells using antibody microarrays , 2006, Molecular Cancer Therapeutics.

[78]  C. Borrebaeck,et al.  Antibody-based microarrays. , 2009, Methods in molecular biology.

[79]  Qing Shao,et al.  Connexins act as tumor suppressors in three-dimensional mammary cell organoids by regulating differentiation and angiogenesis. , 2006, Cancer research.